• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过接种编码缺乏糖基磷脂酰肌醇(GPI)锚定基序的疟原虫环子孢子蛋白的重组腺病毒增强对疟疾的保护性免疫。

Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.

作者信息

Bruna-Romero Oscar, Rocha Carolina D, Tsuji Moriya, Gazzinelli Ricardo T

机构信息

Laboratory of Immunopathology, Centro de Pesquisas René Rachou, FIOCRUZ, Av Augusto de Lima 1715, Belo Horizonte 30190-002, MG, Brazil.

出版信息

Vaccine. 2004 Sep 9;22(27-28):3575-84. doi: 10.1016/j.vaccine.2004.03.050.

DOI:10.1016/j.vaccine.2004.03.050
PMID:15315836
Abstract

A major malaria vaccine candidate, the circumsporozoite (CS) protein of Plasmodium, is a pre-erythrocytic stage antigen that is attached to the surface of the sporozoites through a glycosylphosphatidylinositol (GPI) anchor. However, here we show that the motif that signals for glycosylphosphatidylinositol anchor addition interferes with the immunogenicity of this protein and reduces protection in mice upon immunization with a recombinant adenovirus. The presence of the glycosylphosphatidylinositol-anchoring motif sequentially affected total circumsporozoite protein production, cellular distribution, antigen processing and secretion, leading to less effective antigen presentation. Consistently, vaccination with an adenovirus recombinant carrying the anchoring motif-disrupted circumsporozoite gene, resulted in significant increase of the number of interferon-gamma (IFN-gamma) producing T cells and specific IgG2a isotype antibodies, ensuing more effective vaccination. Given that the anchoring motif is highly conserved among different species of Plasmodium, anti-malaria subunit vaccines encoded by recombinant vectors that aim at the induction of strong cellular immunity could maximize immunogenicity by removing anchoring motifs.

摘要

疟原虫环子孢子(CS)蛋白是一种主要的疟疾疫苗候选物,它是一种前体红细胞期抗原,通过糖基磷脂酰肌醇(GPI)锚定在子孢子表面。然而,我们在此表明,信号介导糖基磷脂酰肌醇锚定添加的基序会干扰该蛋白的免疫原性,并在用重组腺病毒免疫小鼠后降低保护作用。糖基磷脂酰肌醇锚定基序的存在依次影响环子孢子蛋白的总产量、细胞分布、抗原加工和分泌,导致抗原呈递效果降低。同样,用携带破坏锚定基序的环子孢子基因的腺病毒重组体进行疫苗接种,导致产生干扰素-γ(IFN-γ)的T细胞数量和特异性IgG2a同种型抗体显著增加,从而使疫苗接种更有效。鉴于该锚定基序在不同疟原虫物种中高度保守,旨在诱导强烈细胞免疫的重组载体编码的抗疟疾亚单位疫苗可以通过去除锚定基序来最大化免疫原性。

相似文献

1
Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.通过接种编码缺乏糖基磷脂酰肌醇(GPI)锚定基序的疟原虫环子孢子蛋白的重组腺病毒增强对疟疾的保护性免疫。
Vaccine. 2004 Sep 9;22(27-28):3575-84. doi: 10.1016/j.vaccine.2004.03.050.
2
Efficient induction of protective anti-malaria immunity by recombinant adenovirus.重组腺病毒高效诱导保护性抗疟疾免疫
Vaccine. 1998 Nov;16(19):1812-7. doi: 10.1016/s0264-410x(98)00181-9.
3
Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.纳米颗粒制剂增强了 PYGPI8p-转酰胺酶相关蛋白(PyTAM)DNA 疫苗在疟原虫感染模型中的保护性免疫。
Vaccine. 2014 Apr 7;32(17):1998-2006. doi: 10.1016/j.vaccine.2014.01.005. Epub 2014 Jan 15.
4
Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.约氏疟原虫子孢子表面蛋白2线性肽诱导CD4 + T细胞和IFN-γ依赖性清除感染的肝细胞从而预防疟疾
J Immunol. 1996 Nov 1;157(9):4061-7.
5
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.用重组痘苗病毒加强免疫可提高疟疾DNA疫苗的免疫原性和保护效力。
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7648-53. doi: 10.1073/pnas.95.13.7648.
6
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.基于重组人35型腺病毒的疟疾疫苗对约氏疟原虫在小鼠体内的免疫原性及保护作用
Infect Immun. 2006 Jan;74(1):313-20. doi: 10.1128/IAI.74.1.313-320.2006.
7
Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine.重组肽复制合成线性肽嵌合体的免疫原性,用作红细胞前期疟疾疫苗。
Microbes Infect. 2009 Jan;11(1):83-91. doi: 10.1016/j.micinf.2008.10.009. Epub 2008 Oct 26.
8
A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.一种表达疟原虫环子孢子蛋白的重组卡介苗构建体增强树突状细胞的激活,并在 BALB/c 小鼠中诱导针对环子孢子蛋白的记忆细胞。
Vaccine. 2012 Aug 10;30(37):5578-84. doi: 10.1016/j.vaccine.2011.09.054. Epub 2011 Oct 6.
9
Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.针对鼠疟原虫约氏疟原虫环子孢子蛋白特定表位的免疫反应。
Eur J Immunol. 1990 Jun;20(6):1215-22. doi: 10.1002/eji.1830200604.
10
Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.通过多基因DNA免疫规避疟疾保护的遗传限制:依赖CD8 +细胞、γ干扰素和一氧化氮的免疫
J Exp Med. 1996 Apr 1;183(4):1739-46. doi: 10.1084/jem.183.4.1739.

引用本文的文献

1
Germinal center activity and B cell maturation are associated with protective antibody responses against Plasmodium pre-erythrocytic infection.生发中心活性和 B 细胞成熟与针对疟原虫红细胞前期感染的保护性抗体反应有关。
PLoS Pathog. 2022 Jul 6;18(7):e1010671. doi: 10.1371/journal.ppat.1010671. eCollection 2022 Jul.
2
Cell wall glycolipids from Corynebacterium pseudotuberculosis strains with different virulences differ in terms of composition and immune recognition.不同毒力的假结核棒状杆菌细胞壁糖脂在组成和免疫识别方面存在差异。
Braz J Microbiol. 2020 Dec;51(4):2101-2110. doi: 10.1007/s42770-020-00343-9. Epub 2020 Jul 25.
3
Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
基于肺炎球菌表面蛋白 A 的系统和黏膜肺炎球菌疫苗联合加强免疫,增强对致死性肺炎球菌感染的保护作用。
Immunol Res. 2019 Oct;67(4-5):398-407. doi: 10.1007/s12026-019-09107-6.
4
Efficacy and Safety of the Immunization with DNA for Alzheimer's Disease in Animal Models: A Systematic Review from Literature.动物模型中阿尔茨海默病DNA免疫的疗效与安全性:文献系统评价
J Alzheimers Dis Rep. 2017 Dec 2;1(1):195-217. doi: 10.3233/ADR-170025.
5
Comparison of Immunogenicity and Protection of Two Pneumococcal Protein Vaccines Based on PsaA and PspA.基于 PsaA 和 PspA 的两种肺炎球菌蛋白疫苗的免疫原性和保护效果比较。
Infect Immun. 2018 May 22;86(6). doi: 10.1128/IAI.00916-17. Print 2018 Jun.
6
Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.疟疾来源的糖基磷脂酰肌醇锚增强了可阻断疟疾传播的抗Pfs25功能性抗体。
Biochemistry. 2018 Feb 6;57(5):516-519. doi: 10.1021/acs.biochem.7b01099. Epub 2018 Jan 16.
7
A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.一种表达多阶段疟原虫抗原的重组嵌合Ad5/3载体,采用异源初免-加强免疫方案可在小鼠中诱导保护性免疫。
J Immunol. 2016 Oct 1;197(7):2748-61. doi: 10.4049/jimmunol.1501926. Epub 2016 Aug 29.
8
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.一项Ia期研究,旨在评估新型疟疾疫苗候选物ChAd63 CS单独使用及与MVA CS联合使用时的安全性和免疫原性。
PLoS One. 2014 Dec 18;9(12):e115161. doi: 10.1371/journal.pone.0115161. eCollection 2014.
9
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.评估表达环子孢子蛋白和ME-TRAP的ChAd63-MVA载体疫苗对未感染疟疾个体的受控人类疟疾感染的疗效。
J Infect Dis. 2015 Apr 1;211(7):1076-86. doi: 10.1093/infdis/jiu579. Epub 2014 Oct 21.
10
Viral vectors for vaccine applications.用于疫苗应用的病毒载体。
Clin Exp Vaccine Res. 2013 Jul;2(2):97-105. doi: 10.7774/cevr.2013.2.2.97. Epub 2013 Jul 3.